UKRI Translation: MRC Impact Acceleration Awards
The UKRI Translation: MRC Impact Acceleration Awards fund high-risk translational medical research to bridge early innovation and generate crucial data for advancing new or repurposed healthcare solutions.
Funder: UK Research and Innovation
Due Dates: November 11, 2026 (Full application deadline)
Funding Amounts: £50,000–£300,000 per award (up to 18 months; funded at 80% FEC, 100% for permitted exceptions)
Summary: Supports high-risk, single-step translational medical research to bridge early innovation and larger funding, enabling critical data generation for new or repurposed healthcare products.
Key Information: Only one application per project lead; not open to international project leads.
Description
This opportunity provides targeted, single-step funding to accelerate the translation of new or repurposed medicines, medical devices, diagnostics, or other medical products. The goal is to bridge the critical gap between early-stage concept validation and access to larger-scale funding, focusing on high-risk development steps essential for progressing innovative medical interventions. Projects must generate key data to de-risk onward development or determine project viability, sitting strategically between smaller Impact Acceleration Account (IAA) grants and more substantive Proof of Concept schemes. Supported activities include precision prevention, early diagnosis, advanced therapies, digital health, and more, with an emphasis on enhancing patient outcomes and accelerating real-world impact.
